SERANasdaqServices-Medical LaboratoriesFiscal year ends December 31
SERA PROGNOSTICS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$2.03−0.03 (-1.46%)
Close on Oct 19, 2026
- Market cap
- $102.47M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Sera Prognostics has not reported a dividend
No dividend per share appears in Sera Prognostics's annual filings since fiscal 2019.